Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.

Bhatt SP, Nath HP, Kim YI, Ramachandran R, Watts JR, Terry NLJ, Sonavane S, Deshmane SP, Woodruff PG, Oelsner EC, Bodduluri S, Han MK, Labaki WW, Michael Wells J, Martinez FJ, Barr RG, Dransfield MT; SPIROMICS investigators.

Respir Res. 2018 Dec 18;19(1):257. doi: 10.1186/s12931-018-0946-1.

2.

Enhancement of solubility and bioavailability of ambrisentan by solid dispersion using Daucus carota as a drug carrier: formulation, characterization, in vitro, and in vivo study.

Deshmane S, Deshmane S, Shelke S, Biyani K.

Drug Dev Ind Pharm. 2018 Jun;44(6):1001-1011. doi: 10.1080/03639045.2018.1428339. Epub 2018 Feb 5.

PMID:
29382236
3.

Peripheral Odontogenic Fibroma: A Rare Tumor mimicking a Gingival Reactive Lesion.

Khot K, Deshmane S, Bagri-Manjrekar K, Khot P.

Int J Clin Pediatr Dent. 2017 Jan-Mar;10(1):103-106. doi: 10.5005/jp-journals-10005-1416. Epub 2017 Feb 27.

4.

Non-Metabolic Role of PKM2 in Regulation of the HIV-1 LTR.

Sen S, Deshmane SL, Kaminski R, Amini S, Datta PK.

J Cell Physiol. 2017 Mar;232(3):517-525. doi: 10.1002/jcp.25445. Epub 2016 Jun 10.

5.

Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr.

Datta PK, Deshmane S, Khalili K, Merali S, Gordon JC, Fecchio C, Barrero CA.

Cell Cycle. 2016 Sep;15(17):2288-98. doi: 10.1080/15384101.2016.1190054. Epub 2016 May 31.

6.

Human Papilloma Virus in Oral Squamous Cell Carcinoma - The Enigma Unravelled.

Khot KP, Deshmane S, Choudhari S.

Chin J Dent Res. 2016 Mar;19(1):17-23. doi: 10.3290/j.cjdr.a35693. Review.

7.

A cytomorphometric analysis of oral mucosal changes in tobacco users.

Khot K, Deshmane S, Bagri-Manjarekar K, Warke D, Kotak K.

J Nat Sci Biol Med. 2015 Aug;6(Suppl 1):S22-4. doi: 10.4103/0976-9668.166055.

8.

Role of hexokinase-1 in the survival of HIV-1-infected macrophages.

Sen S, Kaminiski R, Deshmane S, Langford D, Khalili K, Amini S, Datta PK.

Cell Cycle. 2015;14(7):980-9. doi: 10.1080/15384101.2015.1006971.

9.

HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis.

Barrero CA, Datta PK, Sen S, Deshmane S, Amini S, Khalili K, Merali S.

PLoS One. 2013 Jul 12;8(7):e68376. doi: 10.1371/journal.pone.0068376. Print 2013.

10.

Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.

Kogan M, Deshmane S, Sawaya BE, Gracely EJ, Khalili K, Rappaport J.

J Cell Physiol. 2013 Apr;228(4):781-90. doi: 10.1002/jcp.24226.

11.

Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins.

Deshmane SL, Amini S, Sen S, Khalili K, Sawaya BE.

Virol J. 2011 Oct 24;8:477. doi: 10.1186/1743-422X-8-477.

12.

High-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons.

Deshmane SL, Mukerjee R, Fan S, Sawaya BE.

PLoS One. 2011 Jan 7;6(1):e16148. doi: 10.1371/journal.pone.0016148.

13.

IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth.

Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M, Pascale M, d'Avenia M, Marzullo L, Belisario MA, De Marco M, Barbieri A, Giudice A, Chiappetta G, Vuttariello E, Monaco M, Bonelli P, Salvatore G, Di Benedetto M, Deshmane SL, Khalili K, Turco MC, Leone A.

Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7497-502. doi: 10.1073/pnas.0907696107. Epub 2010 Apr 5.

14.

Modulation of JC virus transcription by C/EBPbeta.

Romagnoli L, Wollebo HS, Deshmane SL, Mukerjee R, Del Valle L, Safak M, Khalili K, White MK.

Virus Res. 2009 Dec;146(1-2):97-106. doi: 10.1016/j.virusres.2009.09.005. Epub 2009 Sep 9.

15.

Monocyte chemoattractant protein-1 (MCP-1): an overview.

Deshmane SL, Kremlev S, Amini S, Sawaya BE.

J Interferon Cytokine Res. 2009 Jun;29(6):313-26. doi: 10.1089/jir.2008.0027. Review.

16.

HIV-1 Vpr deregulates calcium secretion in neural cells.

Rom I, Deshmane SL, Mukerjee R, Khalili K, Amini S, Sawaya BE.

Brain Res. 2009 Jun 12;1275:81-6. doi: 10.1016/j.brainres.2009.03.024. Epub 2009 Mar 25.

17.

Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression.

Deshmane SL, Mukerjee R, Fan S, Del Valle L, Michiels C, Sweet T, Rom I, Khalili K, Rappaport J, Amini S, Sawaya BE.

J Biol Chem. 2009 Apr 24;284(17):11364-73. doi: 10.1074/jbc.M809266200. Epub 2009 Feb 9.

18.

TNF alpha production in morphine-treated human neural cells is NF-kappaB-dependent.

Sawaya BE, Deshmane SL, Mukerjee R, Fan S, Khalili K.

J Neuroimmune Pharmacol. 2009 Mar;4(1):140-9. doi: 10.1007/s11481-008-9137-z. Epub 2008 Nov 21.

PMID:
19023660
19.

Protective role of Puralpha to cisplatin.

Kaminski R, Darbinyan A, Merabova N, Deshmane SL, White MK, Khalili K.

Cancer Biol Ther. 2008 Dec;7(12):1926-35. Epub 2008 Dec 8.

20.

BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells.

Rosati A, Khalili K, Deshmane SL, Radhakrishnan S, Pascale M, Turco MC, Marzullo L.

J Cell Physiol. 2009 Feb;218(2):264-7. doi: 10.1002/jcp.21604.

21.

Involvement of the p53 and p73 transcription factors in neuroAIDS.

Mukerjee R, Deshmane SL, Fan S, Del Valle L, White MK, Khalili K, Amini S, Sawaya BE.

Cell Cycle. 2008 Sep 1;7(17):2682-90. Epub 2008 Sep 17.

22.

St. John's Wort protein, p27SJ, regulates the MCP-1 promoter.

Mukerjee R, Deshmane SL, Darbinian N, Czernik M, Khalili K, Amini S, Sawaya BE.

Mol Immunol. 2008 Sep;45(15):4028-35. doi: 10.1016/j.molimm.2008.06.001. Epub 2008 Jul 22.

23.

Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells.

Gentilella A, Passiatore G, Deshmane S, Turco MC, Khalili K.

Oncogene. 2008 Aug 28;27(37):5011-8. doi: 10.1038/onc.2008.142. Epub 2008 May 12.

PMID:
18469860
24.

JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis.

Merabova N, Kaniowska D, Kaminski R, Deshmane SL, White MK, Amini S, Darbinyan A, Khalili K.

J Virol. 2008 Feb;82(3):1558-69. Epub 2007 Nov 7.

25.

Molecular mimicry in inducing DNA damage between HIV-1 Vpr and the anticancer agent, cisplatin.

Siddiqui K, Del Valle L, Morellet N, Cui J, Ghafouri M, Mukerjee R, Urbanska K, Fan S, Pattillo CB, Deshmane SL, Kiani MF, Ansari R, Khalili K, Roques BP, Reiss K, Bouaziz S, Amini S, Srinivasan A, Sawaya BE.

Oncogene. 2008 Jan 3;27(1):32-43. Epub 2007 Jul 23.

PMID:
17653096
26.

C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9.

Mameli G, Deshmane SL, Ghafouri M, Cui J, Simbiri K, Khalili K, Mukerjee R, Dolei A, Amini S, Sawaya BE.

J Gen Virol. 2007 Feb;88(Pt 2):631-40.

PMID:
17251582
27.

Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region.

White MK, Skowronska A, Gordon J, Del Valle L, Deshmane SL, Giordano A, Khalili K.

Anticancer Res. 2006 Nov-Dec;26(6B):4079-92.

28.

MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion.

Eldeen MB, Deshmane SL, Simbiri K, Khalili K, Amini S, Sawaya BE.

J Neuroimmunol. 2006 Jul;176(1-2):174-80. Epub 2006 Jun 5.

PMID:
16750572
29.

Precocious axons and improved survival of rat hippocampal neurons on lysine-alanine polymer substrates.

Brewer GJ, Deshmane S, Ponnusamy E.

J Neurosci Methods. 1998 Nov 1;85(1):13-20.

PMID:
9874136
30.

Cytoplasmic domains mediate the ligand-induced affinity shift of guanylyl cyclase C.

Deshmane SP, Parkinson SJ, Crupper SS, Robertson DC, Schulz S, Waldman SA.

Biochemistry. 1997 Oct 21;36(42):12921-9.

PMID:
9335551
31.

Lysosomal degradability of poly(alpha-amino acids).

Chiu HC, Kopecková P, Deshmane SS, Kopecek J.

J Biomed Mater Res. 1997 Mar 5;34(3):381-92.

PMID:
9086408
32.

Increased susceptibility to the pathogenic effects of wild-type and recombinant herpesviruses in MPS VII mice compared to normal siblings.

Wolfe JH, Martin CE, Deshmane SL, Reilly JJ, Kesari S, Fraser NW.

J Neurovirol. 1996 Dec;2(6):417-22.

PMID:
8972424
33.

Rat guanylyl cyclase C expressed in COS-7 cells exhibits multiple affinities for Escherichia coli heat-stable enterotoxin.

Deshmane SP, Carrithers SL, Parkinson SJ, Crupper SS, Robertson DC, Waldman SA.

Biochemistry. 1995 Jul 18;34(28):9095-102.

PMID:
7619807
34.

The replicating intermediates of herpes simplex virus type 1 DNA are relatively short.

Deshmane SL, Raengsakulrach B, Berson JF, Fraser NW.

J Neurovirol. 1995 Jun;1(2):165-76.

PMID:
9222355
35.
37.

A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.

Valyi-Nagy T, Gesser RM, Raengsakulrach B, Deshmane SL, Randazzo BP, Dillner AJ, Fraser NW.

Virology. 1994 Mar;199(2):484-90.

PMID:
8122378
38.
39.

An HSV-1 mutant lacking the LAT TATA element reactivates normally in explant cocultivation.

Deshmane SL, Nicosia M, Valyi-Nagy T, Feldman LT, Dillner A, Fraser NW.

Virology. 1993 Oct;196(2):868-72.

PMID:
8396815
40.

An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers.

Block TM, Deshmane S, Masonis J, Maggioncalda J, Valyi-Nagi T, Fraser NW.

Virology. 1993 Feb;192(2):618-30.

PMID:
8380666
41.

Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice.

Valyi-Nagy T, Deshmane SL, Raengsakulrach B, Nicosia M, Gesser RM, Wysocka M, Dillner A, Fraser NW.

J Virol. 1992 Dec;66(12):7336-45.

42.
43.

In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.

Trousdale MD, Steiner I, Spivack JG, Deshmane SL, Brown SM, MacLean AR, Subak-Sharpe JH, Fraser NW.

J Virol. 1991 Dec;65(12):6989-93.

44.

A herpes simplex virus type 1 mutant lacking the ICP0 introns reactivates with normal efficiency.

Natarajan R, Deshmane S, Valyi-Nagy T, Everett R, Fraser NW.

J Virol. 1991 Oct;65(10):5569-73.

46.
47.

A review of the molecular mechanism of HSV-1 latency.

Fraser NW, Spivack JG, Wroblewska Z, Block T, Deshmane SL, Valyi-Nagy T, Natarajan R, Gesser RM.

Curr Eye Res. 1991;10 Suppl:1-13. Review.

PMID:
1650659
48.

Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia.

Mitchell WJ, Deshmane SL, Dolan A, McGeoch DJ, Fraser NW.

J Virol. 1990 Nov;64(11):5342-8.

49.

A herpes simplex virus type 1 latency-associated transcript mutant reactivates with normal kinetics from latent infection.

Block TM, Spivack JG, Steiner I, Deshmane S, McIntosh MT, Lirette RP, Fraser NW.

J Virol. 1990 Jul;64(7):3417-26. Erratum in: J Virol 1990 Sep;64(9):4603.

Supplemental Content

Loading ...
Support Center